Insider Transactions

What OPIANT PHARMACEUTICALS, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Crystal Roger	Chief Executive Officer	Mar 02	Disposition to Issuer · D	−6,667	$20.00	−$133K	0
Crystal Roger	Chief Executive Officer	Mar 02	Grant / award · A	+6,667	—	—	6,667
Crystal Roger	Chief Executive Officer	Mar 02	Disposition to Issuer · D	−5,100	$20.00	−$102K	0
Crystal Roger	Chief Executive Officer	Mar 02	Disposition to Issuer · D	−37,901	$20.00	−$758K	0
Crystal Roger	Chief Executive Officer	Mar 02	Disposition to Issuer · D	−37,438	$20.00	−$749K	37,901
Daly Richard J	Director	Mar 02	Disposition to Issuer · D	−2,000	$20.00	−$40K	0
Daly Richard J	Director	Mar 02	Disposition to Issuer · D	−5,800	$20.00	−$116K	2,000
Collard Craig A	Director	Mar 02	Disposition to Issuer · D	−53,822	$20.00	−$1.08M	2,000
Collard Craig A	Director	Mar 02	Disposition to Issuer · D	−2,000	$20.00	−$40K	0
O'Toole David D	Chief Financial Officer	Mar 02	Disposition to Issuer · D	−2,000	$20.00	−$40K	0
O'Toole David D	Chief Financial Officer	Mar 02	Grant / award · A	+2,000	—	—	2,000
O'Toole David D	Chief Financial Officer	Mar 02	Disposition to Issuer · D	−11,736	$20.00	−$235K	0
O'Toole David D	Chief Financial Officer	Mar 02	Disposition to Issuer · D	−22,512	$20.00	−$450K	11,736
Ellison Mark Jason Heath	Chief Development Officer	Mar 02	Disposition to Issuer · D	−2,000	$20.00	−$40K	0
Ellison Mark Jason Heath	Chief Development Officer	Mar 02	Grant / award · A	+2,000	—	—	2,000
Ellison Mark Jason Heath	Chief Development Officer	Mar 02	Disposition to Issuer · D	−9,680	$20.00	−$194K	0
Ellison Mark Jason Heath	Chief Development Officer	Mar 02	Disposition to Issuer · D	−11,736	$20.00	−$235K	0
Ellison Mark Jason Heath	Chief Development Officer	Mar 02	Disposition to Issuer · D	−7,015	$20.00	−$140K	11,736
Skolnick Phil	Chief Scientific Officer	Mar 02	Disposition to Issuer · D	−2,000	$20.00	−$40K	0
Skolnick Phil	Chief Scientific Officer	Mar 02	Grant / award · A	+2,000	—	—	2,000

Page 1 of 17 · showing the 20 most recent Sign up free to view all 338 transactions and filter by insider →

Comments